Raia Drogasil S.A. (RADLY)
USD 3.57
(-1.65%)
USD 3.57
(-1.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.06 Billion BRL | 19.38% |
| 2022 | 11.78 Billion BRL | 17.16% |
| 2021 | 10.05 Billion BRL | 6.96% |
| 2020 | 9.4 Billion BRL | 15.06% |
| 2019 | 8.17 Billion BRL | 114.08% |
| 2018 | 3.81 Billion BRL | 18.77% |
| 2017 | 3.21 Billion BRL | 18.01% |
| 2016 | 2.72 Billion BRL | 33.34% |
| 2015 | 2.04 Billion BRL | 28.26% |
| 2014 | 1.59 Billion BRL | 23.72% |
| 2013 | 1.28 Billion BRL | 19.67% |
| 2012 | 1.07 Billion BRL | 11.21% |
| 2011 | 967.13 Million BRL | 198.8% |
| 2010 | 323.66 Million BRL | -0.19% |
| 2009 | 324.29 Million BRL | 37.62% |
| 2008 | 235.64 Million BRL | 18.45% |
| 2007 | 198.94 Million BRL | -8.58% |
| 2006 | 217.61 Million BRL | 37.55% |
| 2005 | 158.2 Million BRL | 69.45% |
| 2004 | 93.36 Million BRL | 34.56% |
| 2003 | 69.38 Million BRL | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 14.82 Billion BRL | 0.06% |
| 2024 Q1 | 14.5 Billion BRL | 3.13% |
| 2023 Q1 | 12.72 Billion BRL | 8.01% |
| 2023 FY | 14.06 Billion BRL | 19.38% |
| 2023 Q3 | 13.59 Billion BRL | 11.92% |
| 2023 Q2 | 12.14 Billion BRL | -4.57% |
| 2023 Q4 | 14.06 Billion BRL | 3.49% |
| 2022 Q3 | 11.41 Billion BRL | 2.8% |
| 2022 Q4 | 11.78 Billion BRL | 3.22% |
| 2022 FY | 11.78 Billion BRL | 17.16% |
| 2022 Q1 | 10.74 Billion BRL | 6.81% |
| 2022 Q2 | 11.1 Billion BRL | 3.37% |
| 2021 FY | 10.05 Billion BRL | 6.96% |
| 2021 Q1 | 9.66 Billion BRL | 2.77% |
| 2021 Q2 | 9.32 Billion BRL | -3.53% |
| 2021 Q3 | 9.61 Billion BRL | 3.19% |
| 2021 Q4 | 10.05 Billion BRL | 4.55% |
| 2020 Q1 | 8.86 Billion BRL | 8.54% |
| 2020 FY | 9.4 Billion BRL | 15.06% |
| 2020 Q4 | 9.4 Billion BRL | 6.63% |
| 2020 Q3 | 8.81 Billion BRL | 2.08% |
| 2020 Q2 | 8.63 Billion BRL | -2.61% |
| 2019 Q4 | 8.17 Billion BRL | -4.72% |
| 2019 FY | 8.17 Billion BRL | 114.08% |
| 2019 Q1 | 7.61 Billion BRL | 99.52% |
| 2019 Q2 | 7.5 Billion BRL | -1.43% |
| 2019 Q3 | 8.57 Billion BRL | 14.25% |
| 2018 FY | 3.81 Billion BRL | 18.77% |
| 2018 Q4 | 3.81 Billion BRL | 2.58% |
| 2018 Q3 | 3.72 Billion BRL | 8.02% |
| 2018 Q2 | 3.44 Billion BRL | 5.28% |
| 2018 Q1 | 3.27 Billion BRL | 1.82% |
| 2017 Q1 | 2.8 Billion BRL | 2.86% |
| 2017 Q2 | 2.98 Billion BRL | 6.57% |
| 2017 FY | 3.21 Billion BRL | 18.01% |
| 2017 Q3 | 3.19 Billion BRL | 7.12% |
| 2017 Q4 | 3.21 Billion BRL | 0.5% |
| 2016 Q2 | 2.09 Billion BRL | -1.22% |
| 2016 FY | 2.72 Billion BRL | 33.34% |
| 2016 Q3 | 2.48 Billion BRL | 18.5% |
| 2016 Q4 | 2.72 Billion BRL | 9.75% |
| 2016 Q1 | 2.11 Billion BRL | 3.79% |
| 2015 Q2 | 1.6 Billion BRL | -3.27% |
| 2015 Q4 | 2.04 Billion BRL | 14.72% |
| 2015 FY | 2.04 Billion BRL | 28.26% |
| 2015 Q1 | 1.66 Billion BRL | 4.34% |
| 2015 Q3 | 1.78 Billion BRL | 10.79% |
| 2014 FY | 1.59 Billion BRL | 23.72% |
| 2014 Q4 | 1.59 Billion BRL | 14.33% |
| 2014 Q3 | 1.39 Billion BRL | 8.9% |
| 2014 Q2 | 1.27 Billion BRL | 7.95% |
| 2014 Q1 | 1.18 Billion BRL | -7.95% |
| 2013 Q1 | 967.54 Million BRL | -10.04% |
| 2013 Q4 | 1.28 Billion BRL | 29.52% |
| 2013 Q3 | 993.77 Million BRL | -2.99% |
| 2013 Q2 | 1.02 Billion BRL | 5.87% |
| 2013 FY | 1.28 Billion BRL | 19.67% |
| 2012 Q4 | 1.07 Billion BRL | 15.51% |
| 2012 FY | 1.07 Billion BRL | 11.21% |
| 2012 Q3 | 931.08 Million BRL | 6.58% |
| 2012 Q1 | 907.56 Million BRL | -6.16% |
| 2012 Q2 | 873.62 Million BRL | -3.74% |
| 2011 FY | 967.13 Million BRL | 198.8% |
| 2011 Q4 | 967.13 Million BRL | 156.46% |
| 2011 Q3 | 377.1 Million BRL | 6.44% |
| 2011 Q2 | 354.29 Million BRL | -8.72% |
| 2011 Q1 | 388.16 Million BRL | 19.93% |
| 2010 Q2 | 257.69 Million BRL | -17.18% |
| 2010 Q3 | 322.41 Million BRL | 25.11% |
| 2010 Q1 | 311.14 Million BRL | -4.06% |
| 2010 Q4 | 323.66 Million BRL | 0.39% |
| 2010 FY | 323.66 Million BRL | -0.19% |
| 2009 FY | 324.29 Million BRL | 37.62% |
| 2009 Q4 | 324.29 Million BRL | 0.0% |
| 2008 FY | 235.64 Million BRL | 18.45% |
| 2007 FY | 198.94 Million BRL | -8.58% |
| 2006 FY | 217.61 Million BRL | 37.55% |
| 2005 FY | 158.2 Million BRL | 69.45% |
| 2004 FY | 93.36 Million BRL | 34.56% |
| 2003 FY | 69.38 Million BRL | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | -445974.474% |
| Allstar Health Brands, Inc. | 9.3 Million USD | -151089.07% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -26453.333% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | -1067286.169% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 543.26 Thousand USD | -2589089.95% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | -194865.411% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | -16198.519% |
| MedGen, Inc. | 43.63 USD | -32239539207.816% |
| Omni Health, Inc. | 1.94 Million USD | -724353.059% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | -1382794.46% |
| Pineapple, Inc. | 10.61 Million USD | -132387.331% |
| ScripsAmerica, Inc. | 9.16 Million USD | -153339.69% |